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Introduction
Selectins are a family of cell surface carbohydrate-binding molecules found on endothelial cells, leukocytes and platelets. They play roles in trafficking of innate immune cells, T lymphocytes and platelets (Ley 2003) . Selectins and their ligands are not only involved in physiological processes such as leukocyte homing (Ley 2003) , but also implicated in pathological processes such as cancer (Natoni et al. 2016 ). In the past decades, selectins and their ligands have been found to play an essential role in the process of human implantation Wang et al. 2008; Liu et al. 2011 ).
Human implantation is a complicated and multifactorial process involving synchrony between a healthy embryo and a receptive endometrium. The appropriate arrival time (around 5.5-6 d after fertilization when a blastocyst is formed), a viable blastocyst and a receptive endometrium are the three essential elements for a successful implantation (Diedrich et al. 2007 ). Furthermore, the attachment at the embryo-endometrium contact surface is the key step in starting a successful implantation process ( Figure 1A ). Understanding the molecular mechanisms involved in such a complex process may lead to improvement in the implantation rate for in vitro fertilization (IVF) and the development of therapies for implantation failure in natural pregnancy.
In the blood vessels, leukocytes capture the endothelium through rolling adhesion and migrate through the vessel wall into tissues. This process is mediated by selectins and their carbohydrate ligands (Alon and Feigelson 2002) . From a morphological point of view, there is a remarkable resemblance between vascular leukocyte extravasation and attachment of the embryo to the endometrium. In The oocyte is fertilized in the ampullary region of the oviduct. The zygote then undergoes cleavage during traveling in the oviduct toward the uterus and reaches 16-cell morula stage. In humans, the morula enters the uterine cavity~4 d after ovulation. Upon arriving in the uterine cavity, fluid starts to penetrate through the zona pellucida into the intercellular spaces of the inner cell mass of the morula and finally a single cavity (blastocele) forms. At this time, the embryo becomes a blastocyst. Cells of the inner cell mass becomes embryoblast aggregates at one pole and the outer flatten epithelial wall (former outer cell mass of the morula) of the blastocyst is called trophoblast. The disappeared zona pellucida allows implantation to begin. Stage 1: The appropriate arrival time (around 5.5-6 d after fertilization), a viable blastocyst and a receptive endometrium are the three essential elements for a successful implantation. The process begins once the correctly apposed free-floating blastocyst-stage embryo is captured by the luminal endometrium. Stage 2: After the blastocyst firmly attaches to the uterine wall, trophoblasts of the outer cell mass start migrating and penetrate the endometrium. After the blastocyst is partially embedded in the endometrium, the trophoblast differentiates into two layers: the cytotrophoblast (inner mononucleated cell layer) and the syncytiotrophoblast (outer multinucleated zone with no distinct cell boundaries). Stage 3: Ultimately the embryo completely embeds beneath the uterine surface. The cytotrophoblast and the syncytiotrophoblast continue to migrate along the maternal blood vessels in the endometrium, and starts forming the fetal portion of the placenta. (B) Initiation of the implantation. L-selectin expressed on the surface of trophoblast and L-selectin ligands expressed on the surface of endometrial epithelium play crucial roles in the adhesion of the blastocyst and endometrial epithelium. (C) Invasion of trophoblast cells in the endometrium. After the implantation is completed, the trophoblast cells continue to proliferate and invade the endometrium. Expression of L-selectin and sialy Le X (ligands binding with P-selectin and E-selectin) is detected on the surface of cytotrophoblasts. The expression of L-selectin ligands is shifted from endometrial epithelial cells to the decidual cells. E-selectin ligands are also detected on the same cells. P-selectin and E-selectin are expressed by vascular endothelial cells of decidual spiral arterioles. Besides, P-selectin is also found in the syncytiotrophoblast. This figure is available in black and white in print and in colour at Glycobiology online.
the latter case, attachment occurs under mucin secretion created flow (Isberg and Barnes 2002) ; implantation begins once the correctly apposed free-floating blastocyst-stage embryo is captured by the luminal endometrium (Norwitz et al. 2001) . After the blastocyst firmly attaches to the uterine wall, trophoblasts of the outer cell mass start migrating and penetrate the endometrium, ultimately embedding the embryo beneath the uterine surface ( Figure 1A ). Embryo development is dependent on the adhesion of trophoblast cells to uterine vessels and the diversion of maternal blood to the placenta. The trophoblast adhesion process is an integrindependent process (Damsky and Fisher 1998; Ilic et al. 2001) , which is also involved in leukocyte extravasation (Drake et al. 2001 ). Therefore, it is possible that the adhesion of the trophoblast to the endometrium in implantation and placentation may involve components of the leukocyte emigration system such as selectins and their carbohydrate-based ligands. This review focuses on the current research progress on the role of selectins and their ligands in the human implantation process.
Selectin and its ligands
Selectins are calcium-dependent, type I transmembrane glycoproteins that mediate the initial interactions between circulating leukocytes and the endothelium (Ley 2003) . Three structurally similar selectins have been identified and their expression can be constitutive or induced depending on the cell type. Activated platelets express P-selectin, activated endothelial cells express E-selectin and P-selectin and leukocytes constitutively express L-selectin. All three selectins have a lectin-like domain at the NH 2 -terminus that is essential for interaction with sialylated carbohydrate moieties on target proteins. The lectin-like domain is followed by an epidermal growth factor-like domain and various numbers of short consensus repeat (CR) domains. Selectins are anchored to the cell surface by a single transmembrane domain and contain a small cytoplasmic tail (Patel et al. 2002) . Selectins and their ligands interact rapidly in order to facilitate the initial tethering and subsequent dissociation that enable leukocyte rolling on the endothelium of vessel walls and ultimately cell extravasation (Chen et al. 1997) .
P-selectin is the longest of the three selectins with nine CRs. At baseline, both endothelial cells and platelets contain P-selectins within secretory granules (Schnaar 2016) . Upon stimulation, endothelial cells and platelets display P-selectin on their surface to recruit leukocytes that express the appropriate ligand. One of the best characterized selectin ligands, P-selectin glycoprotein ligand-1 (PSGL-1), is expressed on the surface of almost all circulating leukocytes and has been shown to play a role in adhesion to endothelial cells and platelets. PSGL-1 can interact with all three selectins but has an especially high affinity for P-selectin (Moore 1998) . The severe reductions in P-selectin-mediated cell rolling and early neutrophil recruitment observed in PSGL-1 deficient mice demonstrate the importance of this ligand for in vivo immune function (Yang et al. 1999 ).
E-selectin contains six CRs but is otherwise structurally similar to P-selectin (Schnaar 2016) . Unlike P-selectin, E-selectin is not stored by endothelial cells and is instead synthesized and translocated to the surface of endothelial cells upon stimulation by inflammatory cytokines. Expression of E-selectin on endothelial cells is, therefore, not as rapid as that of P-selectin following stimulation and maximal levels of E-selectin occur 6-12 h after activation (Leeuwenberg et al. 1992 ). E-selectin recognizes a diverse set of ligands including E-selectin ligand (ESL-1), CD44 and PSGL-1 and this redundancy of ligands that E-selectin can engage makes it unique when compared to P-selectin and L-selectin. ESL-1 is expressed on neutrophils and, unlike PSGL-1, only binds to Eselectin and not to the other two selectins (Chase et al. 2012) .
L-selectin has two CRs and, in contrast to the activationdependent expression of the other two selectins, is displayed constitutively on the surface of circulating leukocytes. L-selectin plays an important role in adaptive immunity because it is expressed on T and B lymphocytes and acts to guide these cells to secondary lymph nodes. Several L-selectin ligands have been identified in high endothelial venules of secondary lymphatic organs and these glycoproteins are collectively known as peripheral node addressins (Sperandio et al. 2003 ). PSGL-1, which is presented by already adherent leukocytes, can also engage L-selectin in inflammatory settings. Additionally, when glycosylated appropriately, L-selectin can serve as a ligand for E-selectin and P-selectin (Chase et al. 2012 ).
The selectins have been shown to contribute to a variety of pathologies. Effective leukocyte recruitment requires selectins and in patients suffering from the rare genetic disorder leukocyte adhesion deficiency type II (LAD-II), the inability to produce selectin ligands results in an increased susceptibility to bacterial infections (Etzioni et al. 1999) . Interestingly, in murine models of LAD-II, animals lacking the fucosyltransferase enzyme that is necessary for appropriate fucosylation of selectin ligands exhibit only minor symptoms (Weninger et al. 2000) . Increased selectin activity, however, has also been implicated in many diseases, particularly in circulatory inflammatory conditions. In a mouse model of sickle cell anemia, E-selectin binding to neutrophils triggers adhesion to sickle red cells to produce pathological inflammation (Hidalgo et al. 2009 ). Also, patients with inflammatory and thrombotic disorders typically have higher levels of activated platelets displaying P-selectin (Totani and Evangelista 2010) . Because of these and other similar observations, selectin antagonists are attractive candidates for therapies to manage inflammatory conditions. The potential of selectin antagonists to treat cancer is another active area of research. Selectin ligands are overexpressed on cancer cells in metastatic disease and selectin activity is involved in tumor extravasation in a process that is similar to leukocyte extravasation (Natoni et al. 2016 ).
Selectins and their ligands in endometrial receptivity
A receptive endometrium is an essential element for successful implantation. The human decidua is characterized by embryoreceptive properties formed during the secretory phase of menstrual cycle from the endometrium. The structures of the decidua include glands, immune cells, blood and lymph vessels, and decidual stromal cells (Brosens et al. 2002; Gellersen and Brosens 2014; Vinketova et al. 2016) . At the molecular level, a receptive endometrium should be able to "capture" the floating blastocyst in the uterine cavity with proper cell surface proteins or ligands.
L-selectin and related ligands
Interestingly, the expression of L-selectin and its ligands on endometrium varies among different species. For instance, L-selectin is found on the bovine endometrium (Bai et al. 2015) , while the major L-selectin ligands are absent in the receptive uterus at the time of murine implantation . This may be why the most relevant research data on L-selectin and its ligands are collected from human samples.
The first evidence of L-selectin ligands involved in the human implantation process came from direct immunostaining results of different stage human endometrial biopsies. MECA-79 (an antibody that specifically recognizes endothelial L-selectin ligands) detected increased expression of L-selectin ligands in the epithelium of endometrium from the follicular (non-receptive) phase to the luteal (receptive) phase . After the completion of implantation, the trophoblast of the blastocyst starts projecting into the decidua, L-selectin expression was detected in the cytotrophoblast (see discussion in Selectins and their ligands in the trophoblast). Accordingly, the expression of L-selectin ligands is shifted to decidual cells, indicating that the L-selectin/ligands adhesion also plays an important role in the penetration of cytotrophoblast into the decidua (Figure 1B and C) . However, the expression of these carbohydrate ligands was lost between the second trimester and birth (Kumamoto et al. 1998; Genbacev et al. 2003) . These findings suggest that ligands related to L-selectin recognition are upregulated as the uterus becomes receptive. Endometrium collected from IVF that had higher levels of L-selectin ligands was associated with an increased pregnancy rate (Wang et al. 2008) . This is consistent with previous studies indicating that L-selectin ligands on the surface of endometrium are crucial for a successful initiation of the blastocyst-endometrium interaction. Immunogold transmission electron microscopy (TEM) revealed the expression of L-selectin ligands in human pinopodes of endometrial epithelium in the mid-luteal phase, which indicated a novel role for pinopodes to be capable of shear-stress-dependent tethering-type adhesion in the initial steps of human embryo implantation (Nejatbakhsh et al. 2012) . Furthermore, the previously mentioned in vitro implantation model demonstrated strong L-selectin expression but not P-selectin and E-selectin on human uterine epithelial cell line (RL95-2) (Liu et al. 2011) . Blocking Lselectin on the surface of RL95-2 cells resulted in activation of endometrial apoptosis, which is essential for the blastocyst to penetrate into the endometrium (Galan et al. 2000; Liu et al. 2011) . Also, some lymphocytes were stained positive for L-selectin in the first trimester human decidua (Ruck et al. 1994 ).
P-selectin, E-selectin and their ligands
P-selectin and E-selectin are expressed by vascular endothelial cells of human decidua basalis (Figure 2 ) at the implantation site but are not found in vessels of the decidua parietalis. Both large and small vessels in the decidua basalis endothelial cells express the two adhesion molecules (Burrows et al. 1994) ; this was similar to the findings from Ruck et al., in which weak E-selectin expression was detected in some arterioles and venules (Ruck et al. 1994 ). Both of P-selectin and E-selectin bind to the carbohydrate ligand sialyl Le x , which is strongly expressed by endovascular trophoblasts (King and Loke 1988) . In addition, in vitro adhesion of cytotrophoblasts to endothelial cells is partially blocked by anti-P-selectin antibodies (Thirkill and Douglas 1999) . King and Loke proposed that trophoblast-endothelial adhesion via sialyl Le x /P-and E-selectin adhesive interaction could be an important mechanism for trophoblast migration within decidual spiral arterioles (Burrows et al. 1994) , which was supported by later studies (Zhou et al. 1997a (Zhou et al. , 1997b James et al. 2012 ). In the decidual tissue of abortion patients, the expression of glycodelin, an E-selectin binding ligand (Jeschke et al. 2003) , was significantly reduced compared to normal gestation (Jeschke et al. 2010 ).
Selectins and their ligands in the trophoblast

L-selectin and related ligands
As the morula enters the uterine cavity, fluid begins to penetrate through the zona pellucida into the space between the inner cell mass and the outer cell mass; eventually, the intercellular spaces form a single cavity called the blastocele. The embryo at this stage is called the blastocyst, of which the inner cell mass becomes the embryoblast and the outer cell mass is the trophoblast. After the blastocyst is partially embedded in the endometrium, the trophoblast differentiates into two layers: the cytotrophoblast (inner mononucleated cell layer) and the syncytiotrophoblast (outer multinucleated zone with no distinct cell boundaries) (Carter et al. 2015) ( Figure 1A ). Once the blastocyst is formed, the zona pellucida is shed to allow implantation to begin. There are many similarities between the processes of lymphocyte rolling under blood flow in blood vessels and blastocyst apposition and adhesion to endometrium under mucin secretion created flow in uterine cavity ) and the two processes may share the same key molecules. Because L-selectin is an essential factor for lymphocyte rolling (Tedder et al. 1990 ), the expression of L-selectin and their ligands on the surface of the embryo has been characterized. Results gathered from IVF showed L-selectin expression on the surface of oocytes (5/5), 2-cell embryos (2/2) and one 6-cell embryo, but not on 8-cell embryos (Campbell et al. 1995) . Blastocysts within the zona pellucida showed either weak or no expression of L-selectin, contrasting the strong expression of L-selectin on the Fig. 2 . The relationship between embryo and uterine decidua. During the implantation process, the endometrium at implantation site undergoes reactive changes, which expands to the entire endometrium. These changes are called decidua reaction. The endometrium after decidua reaction is called decidua. The stromal cells become decidual cells at this time. The decidua is divided into three parts according to the relative position of the embryo: decidua basalis (the deep-surface at the implantation site), decidua capsularis (the decidual layer over the abembryonic pole) and decidua parietalis (the uterine wall on the opposite side of the uterus). Between 2nd and 6th week of gestation, cytotrophoblast and syncytiotrophoblast project out and form a layer of villi on the surface of trophoblast. After 6th week of gestation, villi projected into the decidua basalis flourishes due to the rich nutrients from the blood vessels in the endometrium and form chorion frondosum, which becomes part of the placenta lately. This figure is available in black and white in print and in colour at Glycobiology online.
blastocyst surface after hatching from the zona pellucida . Between 2nd and 6th week of gestation, cytotrophoblast and syncytiotrophoblast project out and form a layer of villi on the surface of trophoblast. After 6th week of gestation, villi projected into the decidua basalis flourishes due to the rich nutrients from the blood vessels in the endometrium and form chorion frondosum (Figure 2) , which becomes part of the placenta. From the 6th to 16th week of gestation, when the chorion frondosum invades the endometrium rapidly, strong expression of L-selectin was observed on cytotrophoblast progenitors, cytotrophoblasts in cell columns and invasive cytotrophoblasts. Notably, high expression of L-selectin was observed in the distal ends of cytotrophoblasts in columns (Zhou et al. 2003; Prakobphol et al. 2006) . In vitro organ culture model studies supported the findings in human biopsies and confirmed that an increase of L-selectin expression is accompanied by an attachment of the blastocyst and, later, the cytotrophoblast to the endometrium . Light and electron microscopic observations showed that the cytotrophoblast degenerates after the 5th month of gestation but remains throughout pregnancy. Accordingly, the expression of L-selectin was reduced or even disappeared on the above cells from the 17th week of gestation to term . Furthermore, L-selectin could not be detected in the first trimester villous placenta (including syncytiotrophoblast and villous stroma) (Campbell et al. 1995) . These findings suggest that L-selectin participates in the initial interaction of the blastocyst with the endometrium and may be important for the establishment and maintenance of column architecture (Prakobphol et al. 2006) . Additionally, the fact that heparins with high proportion of fragments longer than 8 kDa (which could bind with L-selectin) affect blastocyst adhesion by blocking selectin ligand binding sites also supports the above results (Stevenson et al. 2005; Quaranta et al. 2015) . More recently, L-selectin binding mechanics in blastocyst implantation was quantified using three-dimensional cell model, "trophospheres" (Yucha et al. 2014) .
On the other hand, another in vitro implantation model composed of the human trophoblast cell line (JAR) and the human uterine epithelial cell line (RL95-2) demonstrated sialyl Lewis X (sLeX) epitopes (oligosaccharide ligands for L-selectin) can be detected on the surface of JAR cells. The up-regulation of sLeX expression via fucosyltransferase VII (FUT7) (Smith et al. 1996; Laubli et al. 2006) transfection in JAR cells increased the percentage of adhesion of trophoblast cells to RL95-2 cells (Liu et al. 2011) . Moreover, upregulation of sLeX on JAR cells could activate the apoptosis of endometrium, which is essential for the blastocyst to penetrate into the endometrium (Galan et al. 2000; Liu et al. 2011) . Similarly, L-selectin ligands were also found on the surface of bovine conceptus (Bai et al. 2015) .
P-selectin and E-selectin
A weak expression of P-selectin, but not E-selectin, was detected on first and second trimester syncytiotrophoblasts in Genbacev et al.'s (2003) study. However, other studies suggest that E-selectin is involved in the migration of trophoblast cells along the decidual spiral arterioles (Zhou et al. 1997a (Zhou et al. , 1997b James et al. 2012) . Another study using an in vitro human implantation model observed increased E-selectin expression in trophoblast cells when the interaction between trophoblast cells and human uterine myometrial microvascular endothelial cells was inhibited by tumor necrosis factor-α (Xu et al. 2014 ).
Selectins and their ligands in abnormal pregnancies and infertility
Altered expression of selectins and their ligands was found to be associated with abnormal pregnancies and infertility. Immunohistochemistry studies suggested weaker expression of P, L and E-selectin in the decidual cells in uterine decidual stroma of 6-11 weeks missed abortion cases than in the normal controls, while the same was observed in cytotrophoblasts and syncytiotrophoblasts in placental villous stroma (Eskicioglu et al. 2014) . Aberrant expression of E-selectin was found in infertile women with chronic endometritis (Kitaya and Yasuo 2010) . Additionally, altered expression of L-selectin ligands may contribute to abnormal pregnancy and infertility. A study of tubal ectopic pregnancy revealed increased epithelial expression of L-selectin ligands at implantation sites (Li et al. 2014 ). Dysregulation of L-selectin ligand expression has also been observed in other pathologies associated with infertility: the uterine epithelia of polycystic ovarian syndrome and endometriosis patients exhibit a lower expression of L-selectin ligands than that of fertile women (Margarit et al. 2009 ). In fact, screening for the L-selectin ligand MECA-79 has been suggested for patients with repeated implantation failure as the absence of MECA-79 expression in mid-luteal endometrial biopsies was indicative of very low or no chance of pregnancy (Foulk et al. 2007 ).
Conclusion
Taken together, both in vivo and in vitro data suggest that Lselectin and its binding ligands play crucial roles in the initial step of a successful implantation, which is the adhesion of the floating blastocyst to endometrium, and in the subsequent cytotrophoblast invasion into the endometrium. The interaction between P-selectin and E-selectin and their ligands is important for trophoblast migration within decidual spiral arterioles. Moreover, clinical data also demonstrated the association of altered expression of selectins and their ligands in abnormal pregnancies and infertility. However, these data are quite preliminary. Whether the abnormal expression of selectins and their ligands are the results of other causes, or whether they could directly lead to the above results, still remains to be explored. Although drugs such as letrozole and clomiphene citrate were found to be able to raise the epithelial and stromal expression of L-selectin and other endometrial receptivity markers in women with unexplained infertility (Ganesh et al. 2014) , whether these drugs could improve the fertility rate in the patients through enhancing the expression of L-selectin is questionable. Therefore, unveiling the molecular mechanisms and regulating pathways involved in the interaction between selectins and their ligands on the maternal-fetal interface, as well as placentation may not only help to complete the understanding of the human implantation process, but also provide new therapeutic targets for pregnancy loss and other implantation related infertility. 
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